Skip to content

Valganciclovir

Valcyte (valganciclovir) is a small molecule pharmaceutical. Valganciclovir was first approved as Valcyte on 2001-03-29. It is used to treat aids-related opportunistic infections, cytomegalovirus infections, and cytomegalovirus retinitis in the USA. Valcyte's patent is valid until 2027-12-11 (FDA).
Trade Name Valcyte
Common Name Valganciclovir
Indication aids-related opportunistic infections, cytomegalovirus infections, cytomegalovirus retinitis
Drug Class Antivirals: antivirals (acyclovir type)
Valganciclovir
Get full access now